“Vital sign measurements and labs can come too late, but early detection through predictive analytics has the power to improve patients’ outcomes, especially for catastrophic illnesses like COVID-19,” the software's creator said. 

The company, Abridge, aims to help patients gain a better understanding of their own healthcare. 

The AI algorithm was trained using photographs of more than 5,000 patients. 

It has been estimated that more than 200 million people around the world have diabetes and don’t know it. Could AI technology and smartphone cameras help reverse that trend?

The approval means Abiomed can stream patient data from its Impella heart pumps to remote monitoring platforms installed at more than 200 hospitals.

The algorithm, developed as part of a collaboration with Mayo Clinic, received Breakthrough Device designation back in December 2019.

Cardiologs has announced the beginning of a new clinical trial that will involve monitoring the cardiac health of COVID-19 patients being treated with hydroxychloroquine and azithromycin.

An AI algorithm can assess echocardiograms “more rapidly and comprehensively” than experienced cardiologists, according to a new study published in Nature.